BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34861605)

  • 21. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
    Barnard KD; Kropff J; Choudhary P; Neupane S; Bain SC; Kapitza C; Forst T; Link M; Mdingi C; DeVries JH
    J Diabetes Sci Technol; 2018 May; 12(3):634-638. PubMed ID: 28990436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
    Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry.
    Bailey R; Donthi S; Markt S; Drummond C; Cullen J
    J Diabetes Sci Technol; 2023 Nov; 17(6):1580-1589. PubMed ID: 35506181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.
    Tanenbaum ML; Zaharieva DP; Addala A; Prahalad P; Hooper JA; Leverenz B; Cortes AL; Arrizon-Ruiz N; Pang E; Bishop F; Maahs DM
    Diabet Med; 2022 Nov; 39(11):e14923. PubMed ID: 35899591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Glucose Monitoring Decreases Hypoglycemia Avoidance Behaviors, but Not Worry in Parents of Youth With New Onset Type 1 Diabetes.
    Youngkin EM; Majidi S; Noser AE; Stanek KR; Clements MA; Patton SR
    J Diabetes Sci Technol; 2021 Sep; 15(5):1093-1097. PubMed ID: 32522029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-life utilization of real-time continuous glucose monitoring: the complete picture.
    Ramchandani N; Arya S; Ten S; Bhandari S
    J Diabetes Sci Technol; 2011 Jul; 5(4):860-70. PubMed ID: 21880227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.
    Tanenbaum ML; Messer LH; Wu CA; Basina M; Buckingham BA; Hessler D; Mulvaney SA; Maahs DM; Hood KK
    Diabetes Res Clin Pract; 2021 Oct; 180():109048. PubMed ID: 34534592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous glucose monitoring empowers adolescents to take responsibility of diabetes management.
    Williams L; Deacon E; Van Rensburg E; Segal D
    Afr J Prim Health Care Fam Med; 2023 Apr; 15(1):e1-e6. PubMed ID: 37042539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-management among pre-teen and adolescent diabetes device users.
    Faulds ER; Hoffman RP; Grey M; Tan A; Tubbs-Cooley H; Militello LK; Happ MB
    Pediatr Diabetes; 2020 Dec; 21(8):1525-1536. PubMed ID: 32985060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive Functions and Adherence to Continuous Glucose Monitoring in Children and Adolescents with Type 1 Diabetes.
    Farfel A; Liberman A; Yackobovitch-Gavan M; Phillip M; Nimri R
    Diabetes Technol Ther; 2020 Apr; 22(4):265-270. PubMed ID: 31789577
    [No Abstract]   [Full Text] [Related]  

  • 35. Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models.
    Lomax KE; Taplin CE; Abraham MB; Smith GJ; Haynes A; Zomer E; Ellis KL; Clapin H; Zoungas S; Jenkins AJ; Harrington J; de Bock MI; Jones TW; Davis EA
    Front Endocrinol (Lausanne); 2023; 14():1178958. PubMed ID: 37670884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.
    Levitt DL; Silver KD; Spanakis EK
    J Diabetes Sci Technol; 2017 Sep; 11(5):1028-1035. PubMed ID: 28290224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.
    Verbeeten KC; Chan J; Sourial N; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Cooper T; Richardson C; Lawson ML; ;
    Can J Diabetes; 2021 Jul; 45(5):466-472.e4. PubMed ID: 34176610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The efficacy of outpatient monitoring of children and adolescents with type 1 diabetes with regular use of professional continuous glucose monitoring].
    Peterkova VA; Emelyanov AO; Laptev DN; Samoylova YG; Khramova EB; Petriaikina EE; Rybkina IG; Filimonova AY
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):14-22. PubMed ID: 33351309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.